Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer

The purpose of the study: to conduct a systematic literature review on the effectiveness and feasibility of using information on the presence of KRAS gene mutations (in different codons), TP 53 (KP), ST K11/LKB1 (KL), and KEAP mutations and the association of KRAS m with PD -L1 status in patients wi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: K. K. Laktionov, A. M. Kazakov, K. A. Sarantseva, D. S. Scherbo, A. P. Koval
Natura: Artigo
Lingua:Russo
Pubblicazione: Tomsk National Research Medical Center of the Russian Academy of Sciences 2022-03-01
Serie:Sibirskij Onkologičeskij Žurnal
Soggetti:
immunotherapy
kras mutation
pd1-l1 status
co-mutations
liquid biopsy
Accesso online:https://www.siboncoj.ru/jour/article/view/2035
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi